![Guy Ofir](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Guy Ofir
Finanzdirektor/CFO bei RAPHAEL PHARMACEUTICAL INC.
Vermögen: 4 Mio $ am 31.05.2024
Profil
Guy Ofir is currently the Chief Financial Officer & Director at Raphael Pharmaceutical, Inc. since 2021.
He is also the Owner of Mr. Ofir Adv since 2000.
Previously, he worked as the Chief Executive Officer at Easy Energy, Inc. from 2007 to 2010.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
RAPHAEL PHARMACEUTICAL INC
12,39% | 09.05.2024 | 2 312 156 ( 12,39% ) | 4 Mio $ | 31.05.2024 |
Aktive Positionen von Guy Ofir
Unternehmen | Position | Beginn |
---|---|---|
RAPHAEL PHARMACEUTICAL INC. | Finanzdirektor/CFO | 27.09.2021 |
Guy Ofir Adv | Corporate Officer/Principal | 01.01.2000 |
Ehemalige bekannte Positionen von Guy Ofir
Unternehmen | Position | Ende |
---|---|---|
Easy Energy, Inc.
![]() Easy Energy, Inc. Electronic Production EquipmentElectronic Technology Easy Energy, Inc. operates as a pharmaceutical drug research and development company. It focuses on the discovery and clinical development of life-improving drug therapies based on cannabinoids, including cannabidiol, or CBD oil. The company was founded on May 17, 2007 and is headquartered in Tel Aviv-Jaffa, Israel. | Vorstandsvorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Easy Energy, Inc.
![]() Easy Energy, Inc. Electronic Production EquipmentElectronic Technology Easy Energy, Inc. operates as a pharmaceutical drug research and development company. It focuses on the discovery and clinical development of life-improving drug therapies based on cannabinoids, including cannabidiol, or CBD oil. The company was founded on May 17, 2007 and is headquartered in Tel Aviv-Jaffa, Israel. | Electronic Technology |
Raphael Pharmaceutical, Inc. | |
Guy Ofir Adv |